Primary Tumor Resection in Stage IV Breast Cancer: Consistent Benefit, or Consistent Bias?

Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 2002;132:620–6 Rapiti E, Verkooijen HM, Vlastos G, Fioretta G, Neyroud-Caspar I, Sappino AP, Chappuis PO, Bouchardy C. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 2006;24:2743–9 Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 2006;13:776–82 Gnerlich J, Jeffe DB, Deshpande AD, Beers C, Zander C, Margenthaler JA. Surgical Removal of the Primary Tumor Increases Overall Survival in Patients With Metastatic Breast Cancer: Analysis of the 1988–2003 SEER Data. Ann Surg Oncol 2007; DOI 10.1245/s10434-007-9438-0 [Online May 24, 2007] Fields RC, Jeffe DB, Trinkaus K, Zhang Q, Carey A, Aft R, Dietz JR, Eberlein TJ, Gillanders WE, Margenthaler JA. Surgical resection of the primary tumor is associated with increased long-term survival in patients with Stage IV breast cancer after controlling for site of metastasis. Ann Surg Oncol 2007; 14; doi: 10.1245/s10434-007-9527-0 [Online August 9, 2007]. Hazard HW, Gorla SR, Kim J, Scholtens D, Gradishar WJ, Khan SA. Surgical resection of the primary tumor in stage IV breast cancer and survival. Presented at the Society of Surgical Oncology (SSO) 60th Annual Cancer Symposium 2007, vol 14 (suppl), p 84, abstract P174 Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, Piccirillo JF. Differential prognostic impact of comorbidity. J Clin Oncol 2004;22:3099–103 Andre F, Slimane K, Bachelot T, Dunant A, Namer M, Barrelier A, Kabbaj O, Spano JP, Marsiglia H, Rouzier R, Delaloge S, Spielmann M. Breast cancer with synchronous metastases: trends in survival during a 14-year period. J Clin Oncol 2004;22:3302–8 Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JR, Jr., Munshi N, Crawford ED. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001;345:1655–9